Mezzion Pharma Co., Ltd. Stock Price & Chart

KRX: 140410 · 메지온 · KOSPI

₩72,100▲ ₩900 (+1.26%)at close · September 11, 2026
179,90035,85072,100Aug 20, 25Nov 26Mar 06Jun 10Sep 11, 26

Mezzion Pharma Co., Ltd. (메지온, KRX: 140410) last closed at ₩72,100 on September 11, 2026, a +1.26% move on the day. Over the trailing 52 weeks the stock has traded between ₩40,000 and ₩179,900, a +70.45% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩72,100
Day change+1.26%
52-week high₩179,900
52-week low₩40,000

Key Fundamentals

FY 2026.06
Market cap₩2.21T
P/E (PER)-62.16
P/B (PBR)127.39
EPS₩-1,160
BPS₩566
ROE-68.29%
Debt ratio220.79%
Rev. growth14.04%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.06) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-09-11
BullishAlgorithmic summary of 5 standard indicators (net score +5). Describes current technical posture only — not a buy or sell recommendation.
  • ▲ Bullish20-day MAPrice above 67,100
  • ▲ Bullish60-day MAPrice above 60,770
  • ▲ Bullish120-day MAPrice above 70,466
  • ▲ BullishMA trend (20 vs 60)Short-term above mid-term
  • · NeutralRSI (14)RSI 65 — neutral zone
  • ▲ BullishMACD (12,26,9)MACD above signal
52-week position: 23% of rangeRSI(14): 655-day volume vs 20-day: -11%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning Mezzion Pharma Co., Ltd.

No daily reports have covered Mezzion Pharma Co., Ltd. yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.